Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2025-12-25 @ 1:11 AM
NCT ID: NCT02745093
Eligibility Criteria: Inclusion Criteria: * Aged 18 or older * Intrauterine pregnancy 57- 84 days, assessed using clinical assessment and transvaginal or transabdominal ultrasound by crown-rump length (machines will be calibrated and will use a standardized conversion formula to determine gestational age) * Eligible for medical abortion according to doctor assessment * Elected medical abortion over surgical abortion after comprehensive counselling * Haemoglobin level ≥10 g/dl measured by Hemocue * Willing and able to sign consent forms * Able to speak and read Spanish * Agree to comply with the study procedures and visit schedule * Access to own telephone and to emergency transportation * Access to a toilet with privacy * Reside no more than 30 minutes car journey from the Sta. Mónica Hospital in Polanco or the Marie Stopes Mexico Roma Clinic Exclusion Criteria: * History or evidence of disorders that represent a contraindication to the use of mifepristone or misoprostol (chronic adrenal failure, severe asthma uncontrolled by corticosteroid therapy, inherited porphyries, glaucoma, mitral stenosis, hepatic or renal disease) * History of bleeding disorder or current anticoagulant therapy * Previous allergic reaction to any drugs in the regimen * Suspicion of any pathology of pregnancy (e.g. molar, ectopic, non-viable pregnancy) * Multiple gestation * Presence of an intrauterine device
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Study: NCT02745093
Study Brief:
Protocol Section: NCT02745093